AveXis

AveXis, a Novartis company, announced an additional $60 million investment and 200 new jobs at its gene therapy manufacturing site in Durham, North Carolina, bringing total investment to $115 million and planned employment to 400. The facility is expected to be completed in the second half of 2020.

AveXis, a Novartis company, is investing $55 million to build a new manufacturing facility in Durham, North Carolina, creating 200 jobs. The facility will produce gene therapy AVXS-101 for spinal muscular atrophy.